ruthenium has been researched along with norharman in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Ji, L; Lai, S; Lian, W; Peng, W; Tan, C; Wang, M; Wu, S; Xu, A; Zhou, L; Zhu, Y | 1 |
| Chen, J; Chen, L; Chen, M; Jie, X; Li, B; Peng, F; She, J; Zhang, Y; Zou, Z | 1 |
2 other study(ies) available for ruthenium and norharman
| Article | Year |
|---|---|
Synthesis, structures, cellular uptake and apoptosis-inducing properties of highly cytotoxic ruthenium-Norharman complexes.
Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Biological Products; Carbolines; Cell Cycle; Cell Line, Tumor; Cytotoxins; DNA; Harmine; Humans; Inhibitory Concentration 50; Mitochondria; Organometallic Compounds; Pharmacokinetics; Reactive Oxygen Species; Ruthenium; X-Ray Diffraction | 2011 |
Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes.
Topics: Antineoplastic Agents; Apoptosis; Carbolines; Cell Cycle Checkpoints; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Organometallic Compounds; Ruthenium; Structure-Activity Relationship | 2017 |